BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22366902)

  • 1. Photodynamic therapy for symptomatic subretinal fluid related to choroidal nevus.
    García-Arumí J; Amselem L; Gunduz K; Badal J; Adan A; Zapata MA; Valldeperas X; Huste F; Corcóstegui B
    Retina; 2012 May; 32(5):936-41. PubMed ID: 22366902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHOTODYNAMIC THERAPY FOR CHOROIDAL NEVUS WITH SUBFOVEAL FLUID.
    Pointdujour-Lim R; Mashayekhi A; Shields JA; Shields CL
    Retina; 2017 Apr; 37(4):718-723. PubMed ID: 27433882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma.
    Liu W; Zhang Y; Xu G; Qian J; Jiang C; Li L
    Retina; 2011 Feb; 31(2):336-43. PubMed ID: 21102373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic Therapy for Choroidal Metastasis.
    Ghodasra DH; Demirci H
    Am J Ophthalmol; 2016 Jan; 161():104-9.e1-2. PubMed ID: 26432928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin.
    Soucek P; Cihelková I
    Neuro Endocrinol Lett; 2004; 25(1-2):109-14. PubMed ID: 15159693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal Thickness Changes After Photodynamic Therapy and Recurrence of Chronic Central Serous Chorioretinopathy.
    Kim YK; Ryoo NK; Woo SJ; Park KH
    Am J Ophthalmol; 2015 Jul; 160(1):72-84.e1. PubMed ID: 25887629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC; Dijkman G; Boon CJF
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions.
    Caminal JM; Mejia-Castillo KA; Arias L; Catala J; Rubio M; Garcia P; Pujol O; Arruga J
    Retina; 2013 Jan; 33(1):194-9. PubMed ID: 22990320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma.
    Boixadera A; García-Arumí J; Martínez-Castillo V; Encinas JL; Elizalde J; Blanco-Mateos G; Caminal J; Capeans C; Armada F; Navea A; Olea JL
    Ophthalmology; 2009 Jan; 116(1):100-105.e1. PubMed ID: 18973950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of circumscribed choroidal hemangioma.
    Porrini G; Giovannini A; Amato G; Ioni A; Pantanetti M
    Ophthalmology; 2003 Apr; 110(4):674-80. PubMed ID: 12689885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy for choroidal metastasis in 8 cases.
    Kaliki S; Shields CL; Al-Dahmash SA; Mashayekhi A; Shields JA
    Ophthalmology; 2012 Jun; 119(6):1218-22. PubMed ID: 22386261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
    Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
    Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHOTODYNAMIC THERAPY AS PRIMARY TREATMENT FOR SMALL CHOROIDAL MELANOMA.
    Turkoglu EB; Pointdujour-Lim R; Mashayekhi A; Shields CL
    Retina; 2019 Jul; 39(7):1319-1325. PubMed ID: 29659412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.
    Lim JI; Glassman AR; Aiello LP; Chakravarthy U; Flaxel CJ; Spaide RF;
    Ophthalmology; 2014 May; 121(5):1073-8. PubMed ID: 24439758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.
    Nicoló M; Eandi CM; Alovisi C; Grignolo FM; Traverso CE; Musetti D; Cardillo Piccolino F
    Am J Ophthalmol; 2014 May; 157(5):1033-7. PubMed ID: 24487046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma.
    Fabian ID; Stacey AW; Papastefanou V; Al Harby L; Arora AK; Sagoo MS; Cohen VM;
    Eye (Lond); 2017 Apr; 31(4):519-528. PubMed ID: 28338667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus.
    Parodi MB; Boscia F; Piermarocchi S; Ferrari TM; Furino C; Sborgia C
    Retina; 2005 Jun; 25(4):438-42. PubMed ID: 15933589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
    Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
    Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome.
    Di Nicola M; Williams BK; Srinivasan A; Al-Dahmash S; Mashayekhi A; Shields JA; Shields CL
    Ophthalmol Retina; 2020 Oct; 4(10):1024-1033. PubMed ID: 32344158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.